Hypera S.A. (OTCMKTS:HYPMY) Sees Large Decrease in Short Interest

Hypera S.A. (OTCMKTS:HYPMYGet Rating) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 8,200 shares, a drop of 62.4% from the April 15th total of 21,800 shares. Based on an average daily volume of 17,100 shares, the days-to-cover ratio is currently 0.5 days.

Hypera stock traded up $0.01 during trading hours on Friday, hitting $7.37. 4,178 shares of the stock traded hands, compared to its average volume of 11,619. The firm’s 50-day moving average price is $7.60 and its two-hundred day moving average price is $6.16. The company has a market cap of $4.67 billion, a PE ratio of 16.88 and a beta of 0.73. Hypera has a one year low of $4.63 and a one year high of $8.65.

Hypera Company Profile (Get Rating)

Hypera SA operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands.

See Also

Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.